RxDoctor Payments Data

Andrea Albrigo

Medical · Las Vegas, NVNPI 1740314665

Payments from drug & device makers

$2,415in general payments, 2019–2025

Across 170 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$1K
  • Collegium Pharmaceutical, Inc.$449
  • Medtronic$261
  • Biotronik NRO, Inc.$241
  • Abbott$108
  • Nalu Medical, Inc.$63
  • plus $66 from 3 others

What the payments were for

  • Food & beverage$2,415100%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,415 in reported general payments places this provider in the 70th percentile of 250 medical providers in Nevada.

See all medical providers in Nevada

Medicare billing

Part B allowed, 2024
$71,603
Medicare patients
214
Services billed
3,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,662$90,667
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,332$47,300
Xtampza ErOxycodone Myristate55$28,297
Gabapentin925$11,283
BelbucaBuprenorphine Hcl16$10,792
LyricaPregabalin11$10,172
Diclofenac Sodium236$9,292
Lidocaine101$8,674
Oxycodone Hcl597$7,348
OxycontinOxycodone Hcl12$7,301
Morphine Sulfate ErMorphine Sulfate306$7,172
ZtlidoLidocaine11$6,368
Pregabalin235$4,821
Tizanidine Hcl472$4,360
Morphine Sulfate127$3,912

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$449$39,08971 claims
Scilex Pharmaceuticals Inc.Ztlido$1,228$6,36811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 250 medical providers in Nevada.

Other medical in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →